本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Nuo Therapeutics, Inc.

2.38
+0.380019.00%
成交量:2,992.00
成交額:6,078.37
市值:1.14億
市盈率:-37.28
高:2.38
開:2.00
低:2.00
收:2.00
52周最高:3.23
52周最低:0.7000
股本:4,807.77萬
流通股本:2,286.42萬
量比:0.68
換手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-0.0638
每股收益(LYR):-0.0293
淨資產收益率:-1032.50%
總資產收益率:-87.97%
市淨率:-272.70
市盈率(LYR):-81.36

資料載入中...

2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/20

重要事件披露

Form 8-K - Current report
2023/11/21

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/05/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/18

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/12/05

重要事件披露

8-K - Current report
2022/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/30

重要事件披露

8-K - Current report
2022/08/30

重要事件披露

8-K - Current report
2022/08/10

[修訂]季度報告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2022/08/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/05

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/07/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/28

重要事件披露

8-K - Current report